Net Income (TTM) Chart

Historical Net Income (TTM) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 78.93M
March 31, 2026 -120.53M
December 31, 2025 -114.20M
September 30, 2025 -168.69M
June 30, 2025 -157.50M
March 31, 2025 -167.33M
December 31, 2024 -147.79M
September 30, 2024 -88.18M
June 30, 2024 -93.14M
March 31, 2024 -74.10M
December 31, 2023 -84.03M
September 30, 2023 -141.53M
June 30, 2023 -131.20M
March 31, 2023 -132.67M
September 30, 2022 -112.21M
June 30, 2022 -100.88M
March 31, 2022 -86.99M
Date Value
December 31, 2021 -79.56M
September 30, 2021 -80.11M
June 30, 2021 -60.60M
March 31, 2021 -65.93M
December 31, 2020 -57.99M
September 30, 2020 -53.01M
June 30, 2020 -57.04M
March 31, 2020 -52.45M
December 31, 2019 -54.75M
September 30, 2019 -70.32M
June 30, 2019 -75.29M
March 31, 2019 -84.92M
December 31, 2018 -83.34M
September 30, 2018 -70.79M
June 30, 2018 -62.54M
March 31, 2018 -38.90M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (TTM) Range, Past 5 Years

View Net Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (TTM) Benchmarks

View Net Income (TTM) Benchmarks
Start Trial
Xencor, Inc. -163.32M
UroGen Pharma Ltd. -97.64M
Ironwood Pharmaceuticals, Inc. 129.87M
Viking Therapeutics, Inc. -534.80M
IDEAYA Biosciences, Inc. -175.02M